BM
Bridger Management’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,083,598
| Closed | -$38.6M | – | 32 |
|
|
2019
Q2 | $38.6M | Sell |
1,083,598
-154,891
| -13% | -$5.51M | 3.03% | 15 |
|
|
2019
Q1 | $41.6M | Buy |
1,238,489
+104,075
| +9% | +$3.5M | 3.29% | 14 |
|
|
2018
Q4 | $37.3M | Hold |
1,134,414
| – | – | 3.11% | 16 |
|
|
2018
Q3 | $69.2M | Hold |
1,134,414
| – | – | 4% | 9 |
|
|
2018
Q2 | $55.4M | Buy |
1,134,414
+465,922
| +70% | +$22.8M | 3% | 15 |
|
|
2018
Q1 | $71M | Sell |
668,492
-698,679
| -51% | -$74.2M | 4.31% | 6 |
|
|
2017
Q4 | $81.6M | Sell |
1,367,171
-907,490
| -40% | -$54.2M | 5.39% | 4 |
|
|
2017
Q3 | $54.6M | Sell |
2,274,661
-536,431
| -19% | -$12.9M | 3.27% | 13 |
|
|
2017
Q2 | $55M | Sell |
2,811,092
-126,163
| -4% | -$2.47M | 3.14% | 11 |
|
|
2017
Q1 | $68.9M | Sell |
2,937,255
-1,007,437
| -26% | -$23.6M | 3.93% | 7 |
|
|
2016
Q4 | $48.4M | Buy |
3,944,692
+1,112,056
| +39% | +$13.6M | 3.37% | 16 |
|
|
2016
Q3 | $48.7M | Sell |
2,832,636
-765,918
| -21% | -$13.2M | 3.28% | 13 |
|
|
2016
Q2 | $51.2M | Buy |
3,598,554
+81,543
| +2% | +$1.16M | 3.31% | 14 |
|
|
2016
Q1 | $48.4M | Buy |
3,517,011
+1,953,149
| +125% | +$26.9M | 3.34% | 15 |
|
|
2015
Q4 | $26.4M | Buy |
+1,563,862
| New | +$26.4M | 0.87% | 23 |
|